Metastatic Castration Resistant Prostate Cancer Life Expectancy

Overall Survival And Second Primary Malignancies In Men With Metastatic Prostate Cancer

• Roles Conceptualization, Investigation, Methodology, Writing review & editing

  Affiliation Bayer LLC, Whippany, New Jersey, United States of America

• Roles Conceptualization, Investigation, Methodology, Writing review & editing

  Affiliation Bayer LLC, Whippany, New Jersey, United States of America

• Roles Conceptualization, Investigation, Methodology, Writing review & editing

  Affiliation Bayer AB, Stockholm, Sweden

• Roles Conceptualization, Investigation, Methodology, Writing review & editing

  Affiliation Bayer AG, Berlin, Germany

• Roles Resources, Writing review & editing

  Affiliation Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

• Roles Data curation, Formal analysis, Software, Visualization, Writing original draft

  Affiliation EPID Research, Espoo, Finland

Remission And The Chance Of Recurrence

A remission is when cancer cannot be detected in the body and there are no symptoms. This may also be called having no evidence of disease or NED.

A remission can be temporary or permanent. This uncertainty causes many people to worry that the cancer will come back. Although there are treatments to help prevent a recurrence, such as hormonal therapy and radiation therapy, it is important to talk with your doctor about the possibility of the cancer returning. There are tools your doctor can use, called nomograms, to estimate someone’s risk of recurrence. Understanding your risk of recurrence and the treatment options may help you feel more prepared if the cancer does return. Learn more about coping with the fear of recurrence.

In general, following surgery or radiation therapy, the PSA level in the blood usually drops. If the PSA level starts to rise again, it may be a sign that the cancer has come back. If the cancer returns after the original treatment, it is called recurrent cancer.

When this occurs, a new cycle of testing will begin again to learn as much as possible about the recurrence, including where the recurrence is located. The cancer may come back in the prostate , in the tissues or lymph nodes near the prostate , or in another part of the body, such as the bones, lungs, or liver . Sometimes the doctor cannot find a tumor even though the PSA level has increased. This is known as a PSA recurrence or biochemical recurrence.

What Is Stage 4 Prostate Cancer

The fourth stage of prostate cancerdefines a tumor that has progressed to other regions of the body, such as the lymph nodes, lungs, liver, bones, or bladder. The 5-year survival rate for these tumors is 29 percent.

Keep in mind that each case is unique, and figures like these are merely suggestions. As advances in prostate cancer treatment become more common, your odds of surviving this disease improve.

In general, prostate cancer has a very good survival rate one of the greatest of any cancer type. Because prostate cancer is frequently a slow-moving disease, the majority of men diagnosed with it will die from an unrelated reason.

Stage 4 prostate cancer means the cancer has spread to lymph nodes or to other parts of the body. It is further divided into two substages:

• Prostate Cancer Stage 4A Stage 4A: The cancer has spread to nearby lymph nodes but may or may not have spread to nearby tissues.

• Prostate Cancer Stage 4B Stage 4B: The cancer has spread to another area of the body, such as the bones or distant lymph nodes.

Also Check: How To Tell If You Have Prostate Problems

First Line Treatment For Advanced Prostate Cancer

The established first line approach is to control the progression of the disease by reducing levels of testosterone in the body. This is because testosterone increases the speed at which prostate cancer cells reproduce.

There are two different ways to lower testosterone levels. Hormone therapy lowers the levels of testosterone in the body by taking tablets or having injections. It is sometimes referred to as medical castration. The surgical option involves removing the testicles, known as surgical castration or orchidectomy, although this is now rarely used.

Another approach is called anti-androgen treatment. Androgens have to bind to a protein in the cell called an androgen receptor to work. Anti-androgens are drugs that bind to these receptors so the androgens cant, effectively blocking them. The main side-effects are gynaecomastia breast enlargement and breast pain, although a single radiotherapy dose to the breasts can help this side-effect.

Combining anti-androgens with testosterone reduction is known as Maximum Androgen Blockade and may be used if hormone treatment alone is not working sufficiently.

Treating with chemotherapy at the same time as the start of hormone deprivation was found to increase survival by 13 months in all patients and 17 months in men with high-volume disease.

Quality Of Life With Mcrpc

According to a review published in the British Medical Journal in October 2016, you may not experience pain or other symptoms at this stage of cancer, or you may experience many. Its different for everyone. So along with treating the cancer itself, be sure to talk to your doctors about any symptoms and side effects youre experiencing in order so that the right ways to alleviate them can be found. You should also ask your care team about options for palliative care.

Because it can be very stressful to have advanced prostate cancer, and tough to talk about what it all means for your future, the ASCO urges men to have an open and honest conversation with their care team. Discuss what youre worried about, and whats important to you. There are many ways to look for and get emotional support.

Additional reporting by Andrea Peirce

Don’t Miss: How To Screen Prostate Cancer

Survival For All Stages Of Prostate Cancer

Generally for men with prostate cancer in England:

• more than 95 out of 100 will survive their cancer for 1 year or more
• more than 85 out of 100 will survive their cancer for 5 years or more
• almost 80 out of 100 will survive their cancer for 10 years or more

Survival for prostate cancer is also reported in Scotland and Northern Ireland. But it is difficult to compare survival between these countries because of differences in the way the information is collected.

Cancer survival by stage at diagnosis for England, 2019Office for National Statistics

These statistics are for net survival. Net survival estimates the number of people who survive their cancer rather than calculating the number of people diagnosed with cancer who are still alive. In other words, it is the survival of cancer patients after taking into account the background mortality that they would have experienced if they had not had cancer.

Intermittent Versus Continuous Therapy

The common complications of androgen deprivation therapy include sexual dysfunction, mood disturbance, change in body composition and osteoporosis.2,3 In view of these adverse effects intermittent dosing has been considered. This is a period of androgen deprivation therapy followed by a break until disease progression, if a good response was attained. The optimal duration of androgen deprivation therapy is fairly arbitrary as the studies have looked into various periods ranging from three months to three years.

In patients with PSA relapse only , intermittent therapy has been shown to be non-inferior to continuous dosing. There was also a better quality of life with intermittent dosing.4

In patients with objective metastases, intermittent androgen deprivation therapy had numerically worse outcomes than continuous treatment, but the study was statistically inconclusive. There was less sexual dysfunction and better mental health in the intermittent group, but this effect disappeared by 15 months when most people were back on continuous treatment.5 If short-term quality of life is important, even at the risk of possible worse survival, intermittent therapy is a reasonable approach.

Don’t Miss: Can You Drink Alcohol After A Prostate Biopsy

How Is Prostate Cancer Staged

Prostate cancer is one of the most common types of cancer that develops in men and is the second leading cause of cancer deaths in American men, behind lung cancer and just ahead of colorectal cancer. The prognosis for prostate cancer, as with any cancer, depends on how advanced the cancer has become, according to established stage designations.

The prostate gland is a walnut-sized gland present only in men, found in the pelvis below the bladder. The prostate gland wraps around the urethra and lies in front of the rectum. The prostate gland secretes part of the liquid portion of the semen, or seminal fluid, which carries sperm made by the testes. The fluid is essential to reproduction.

The term to stage a cancer means to describe the evident extent of the cancer in the body at the time that the cancer is first diagnosed.

• Clinical staging of prostate cancer is based on the pathology results, physical examination, PSA, and if appropriate, radiologic studies.
• The stage of a cancer helps doctors understand the extent of the cancer and plan cancer treatment.
• Knowing the overall results of the different treatments of similarly staged prostate cancers can help the doctor and patient make important decisions about choices of treatment to recommend or to accept.

Recommended Reading: How Painful Is A Biopsy Of The Prostate

Does Crpc Affect Different Ethnic/racial Groups Differently

Non-Hispanic Black people are much more likely to get prostate cancer than those of any other race or ethnicity. Prostate cancer rates are lowest among non-Hispanic Asian Americans. Black people also are more likely than non-Black people to be diagnosed with advanced prostate cancer. But in treatment, Black people have at least similar outcomes compared to non-Black people. Researchers donât fully understand the reasons for these differences.

Show Sources

You May Like: Can Prostate Cancer Be Cured With Radiation

Prognostic Assessment: Is Psadt Enough

Prostate-specific antigen doubling time has been considered a prognostic marker in retrospective studies, but that has been difficult to validate in prospective assessments . The optimal time interval between PSA values for estimating PSADT and its optimal limits still need to be determined.

In the case of M0 CRPC, PSA indirectly monitors tumor activity from the androgen receptor signal, which can correlate with tumor growth. However, it should be noted that PSA decline has not been proven to be a marker of survival or outcome, and androgen receptor downregulation does not always represent tumor cell elimination. In fact, it is acknowledged that some aggressive prostate cancers are low PSA secretors .

Recent studies have shown that PSA levels and PSADT are important tools in prognostic risk assessment in prostate cancer. Baseline PSA level, PSA velocity, and PSADT have been associated with the time to bone metastases, metastasis-free survival , and overall survival in M0 CRPC . However, while PSA levels are clearly defined through testing, a PSADT calculation can be less straightforward.

Treatments To Control And Prevent Further Cancer Spread In Patients With Castrate Refractory Advanced Prostate Cancer:

At BPC we offer:

• Hormones , Enzalutamide , Diethylstilboestrol)
• Chemotherapy .
• Radium-223

Other treatment options ongoing clinical studies:

• Autologous cellular immunotherapy, which is in late trial stage and although not currently available outside a trial setting in the UK, is likely to be licensed soon.
• Cabozantinib

You May Like: What Is Castration Resistant Prostate Cancer

Treatments To Help Manage Symptoms

Advanced prostate cancer can cause symptoms, such as bone pain. Speak to your doctor or nurse if you have symptoms there are treatments available to help manage them. The treatments above may help to delay or relieve some symptoms. There are also specific treatments to help manage symptoms you may hear these called palliative treatments. They include:

This is the team of health professionals involved in your care. It is likely to include:

• a specialist nurse

Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis And Treatment

• 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States
• 2Department of Urology, University of Kansas Medical Center, Kansas City, KS, United States
• 3Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, United States
• 4Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, United States

Editorial on the Research TopicMetastatic Castration Resistant Prostate Cancer: Prognosis and Treatment

Figure 1 Diagnosis and treatment landscape of prostate cancer. Figure was created using BioRender.com.

Irrespective of the treatment modalities, most CRPC patients develop bone metastasis. The metanalysis by Tong et al. assessed the prognostic value of skeletal-related parameters in mCRPC overall survival. This study examined the association between alkaline phosphatase, bone-specific alkaline phosphatase, urinary N-telopeptide, bone scan index, and overall survival in patients with metastatic PCa. The analysis revealed that higher levels of ALP, BSAP, and uNTx, progression of BSI, as well as BPI-SF scores were associated with lower OS in randomized controlled trials published between 2010 and 2019. Considering the ambiguity of the PSA value in mCRPC, bone-related parameters, AR variants, and, more importantly, CTC can help stratify the risk of mCRPC patients before the start of treatment.

Don’t Miss: How To Stimulate Your Prostate

Survival Rates By Tnm Stage

The first approach is based on the TNM stage statistical survival times are matched to the stage of the disease.

By contrast, the one-year survival rate for stage 4 lung cancer was reported in one study to be between 15% and 19%, meaning this portion of patients with metastatic disease lived for at least a year.

Also Check: Prostate Cancer That Has Spread

Diagnostic Challenges: What Is The Impact Of New Imaging Modalities In M0 Crpc Detection

Prostate cancer staging has been traditionally performed through conventional imaging techniques, such as a technetium-99m bone scan and chest, abdomen, and pelvic computed tomography . However, these methods have limited accuracy to detect prostate cancer metastases. The CT scan has a sensitivity of 42% in the detection of metastatic lymph nodes and a bone scan has a sensitivity of 5979% and a specificity of 7582% in the detection of bone metastases, as shown in the meta-analysis by Shen et al. .

Given this body of evidence, the RADAR III group recommended that if traditional imaging fails to detect metastatic disease, next-generation imaging can be performed only if approved therapies in the low-volume metastatic space are being considered . In Portugal, although there are no official figures, the use of this method is not uniform across the country, with a trend toward greater use in academic hospitals and oncology centers.

Overall, the emergence of these highly sensitive imaging modalities will challenge the conceptual setting of M0 CRPC, as a growing number of patients will be diagnosed with early metastatic disease instead of M0 disease, with a direct impact on their treatment plan. Nevertheless, considering the lack of clinical trials assessing the prognosis of patients with metastases detected only by PSMA, further investigation is needed as to whether PSMA PET/CT should be extensively used in high-risk patients .

Also Check: How Deep Is Prostate Gland

Prostate Cancer Is Common With Aging

After skin cancer, prostate cancer is the most common cancer in men. About 1 in 7 men will be diagnosed with prostate cancer in their lifetime. And these are just the men who are diagnosed. Among very elderly men dying of other causes, a surprising two-thirds may have prostate cancer that was never diagnosed.

Only 1 in 36 men, though, actually dies from prostate cancer. Thats because most prostate cancers are diagnosed in older men in whom the disease is more likely to be slow-growing and non-aggressive. The majority of these men eventually pass away from heart disease, stroke, or other causes not their prostate cancer.

Prognosis And Survival For Prostate Cancer

If you have prostate cancer, you may have questions about your prognosis. A prognosis is the doctors best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors. Only a doctor familiar with your medical history, the type and stage and other features of the cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis.

A prognostic factor is an aspect of the cancer or a characteristic of the person that the doctor will consider when making a prognosis. A predictive factor influences how a cancer will respond to a certain treatment. Prognostic and predictive factors are often discussed together. They both play a part in deciding on a treatment plan and a prognosis.

The following are prognostic and predictive factors for prostate cancer.

Recommended Reading: How To Give Yourself A Prostate Massage

Managing Bone Pain And Weakness

Symptoms like nausea, hot flashes, and pain can usually be relieved with medication. Some people find that complimentary treatments like acupuncture or massage help manage side effects.

Your doctor may also recommend orthopedic surgery to stabilize your bones, relieve pain, and help prevent bone fractures.

Is Metastatic Cancer Always Terminal

This cancer stage has high mortality risk. However, in most cases, stage 4 or metastatic cancer is not always terminal. It is all depending on the spread area and case. On the other hand, it is also the stage where more advanced and aggressive treatment is necessary to kill the cancer cell.

Terminal cancer refers to a cancer case that is impossible to cure. This case mostly will result in the death of the patient. Therefore, the treatment for terminal cancer is only to control the spread and ease the patients pain. The curing process is difficult to do. So, it is the period when doctors and patients families prepare for the worst.

Despite its obvious result, the medical world still sets the standard for the patients survival likelihood. And, to learn more about that matter, you can continue reading. We will start talking about our main topic here, the stage 4 cancer life expectancy.

Recommended Reading: How To Ejaculate From Prostate